TY - JOUR
T1 - Correction to
T2 - Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer (Breast Cancer Research and Treatment, (2020), 183, 1, (107-116), 10.1007/s10549-020-05750-y)
AU - Ham, Ahrong
AU - Kim, Min Hwan
AU - Kim, Gun Min
AU - Kim, Jee Hung
AU - Kim, Jee Ye
AU - Park, Hyung Seok
AU - Park, Seho
AU - Cho, Young Up
AU - Park, Byeong Woo
AU - Kim, Seung Il
AU - Sohn, Joohyuk
N1 - Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - In the original publication of the article, under the Results section, subheading “Patient survival”, the second sentence that reads as “The 6-month PFS was 92.4%, 81.8%, and 93.3% and the one-year PFS was 72.0%, 88.9%, and 78.9% in Groups 1–3, respectively.” should read as "The 6-month PFS was 82.8%, 75.0%, and 68.0% and the one-year PFS was 77.0%, 62.0%, and 63.8% in Groups 1–3, respectively.".
AB - In the original publication of the article, under the Results section, subheading “Patient survival”, the second sentence that reads as “The 6-month PFS was 92.4%, 81.8%, and 93.3% and the one-year PFS was 72.0%, 88.9%, and 78.9% in Groups 1–3, respectively.” should read as "The 6-month PFS was 82.8%, 75.0%, and 68.0% and the one-year PFS was 77.0%, 62.0%, and 63.8% in Groups 1–3, respectively.".
UR - http://www.scopus.com/inward/record.url?scp=85087837229&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087837229&partnerID=8YFLogxK
U2 - 10.1007/s10549-020-05796-y
DO - 10.1007/s10549-020-05796-y
M3 - Comment/debate
C2 - 32661666
AN - SCOPUS:85087837229
SN - 0167-6806
VL - 183
SP - 493
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 2
ER -
